Home Search
glaucoma - search results
If you're not happy with the results, please do another search
COVID-19 and diabetes telehealth
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.
CBD: Narcotic substance or a novel food product?
CBD is at the forefront of pharmacology. So why has the European Commission changed its recommended status to “Narcotic”? Read on to find out more.
The role of technology in ophthalmology
Mr Romesh Angunawela, Founding Partner, Ophthalmic Consultants of London, enlightens us on the role of technology in ophthalmology as part of the NHS’s efforts to tackle the COVID backlog.
Machine learning will help to grow artificial organs
Researchers in Moscow and America have discovered how to use machine learning to grow artificial organs, especially to tackle blindness.
Understanding the connection between vision loss and mental health
Victoria Johnson from Vision Loss Rehabilitation Canada sheds light on the connection between vision loss and mental health.
The silence before the tsunami: COVID is devastating behind NHS virus frontlines
Doctor Allon Barsam, consultant eye surgeon and founder of Ophthalmic Consultants of London, calls attention to the unexplored devastation behind the NHS virus frontlines.
Seeing the way forward for eye care in the UK
Debbie McGill, Head of Policy and Public Affairs at the Association of British Dispensing Opticians, tells us all we need to know on accessing eye care and the leading causes of sight loss in the UK.
Early detection is crucial to prevent blindness from diabetic retinopathy
Emily Y. Chew, M.D., Director of the Division of Epidemiology and Clinical Applications and the Deputy Clinical Director at the National Eye Institute, part of the National Institutes of Health, examines why early detection is crucial to prevent blindness from diabetic retinopathy.
Research on visual impairment diseases by the U.S.
Here, Open Access Government explore how the National Eye Institute in the U.S is supporting vision research that encompasses visual impairment diseases of people of all ages.
How diabetes can affect the eyes
With diabetes on the increase in the UK, Dr Louise Gow, Specialist Lead for Eye Health at The Royal National Institute of Blind People (RNIB) explains more about the condition and how it can affect the eyes.
Understanding chronic autoimmune uveitis through ophthalmology research
Andrew Taylor, Professor of Ophthalmology, highlights research to understand the molecules that mediate ocular immune privilege so they can be adapted for chronic autoimmune uveitis.
Ophthalmology: A focus on uveitis – the inflammation of the uveal tract
Dr Gerry Morrow explains what you need to know about an aspect of ophthalmology called uveitis, defined as inflammation of the uveal tract, which comprises the iris, ciliary body and choroid.
Cannabinoids for therapeutic purposes – where are we?
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group shares a perspective on the present status and potential evolution when it comes to cannabinoids for therapeutic purposes.
Advancing research and developing new therapies for inherited retinal eye diseases
Takeshi Iwata, Division Director at the National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, tells us about advancing research and developing new therapies for inherited retinal eye diseases.
Eye health progress and impact: Protecting and prolonging vision by research
To mark its 50-year anniversary, the National Eye Institute (NEI) takes stock of its progress in advancing vision research and developing new therapies to treat blinding diseases
How can we make eye screening services more available?
OPTOMED explains the importance of our sight and that many of us are not aware of the importance of systematic eye checks.
Out of sight: Low vision is a National Eye Institute priority
Low vision can be a blight on the lives of those it affects, which is why it’s a National Eye Institute priority, as Dr Cheri Wiggs told Open Access Government
Around 4.2 million people in America are visually impaired, which is expected to increase to 7.2 million in 2030. Of...